Overview

Study of Lamotrigine to Treat Ménière's Disease

Status:
Completed

Trial end date:
2017-03-01

Target enrollment:

Participant gender:

Summary

This double-blinded study evaluates the frequency of vertigo attacks and the quality of life of patients diagnosed with Ménière's disease after being randomly assigned to take a placebo or lamotrigine.

Phase:

Phase 3

Details

Lead Sponsor:

Dent Neuroscience Research Center

Collaborators:

Ernesto Diaz-Ordaz, MD
University at Buffalo

Treatments:

Anticonvulsants
Lamotrigine